Flanagan, managing partner of Sidley Austin’s San Francisco office, is recognized for her dealmaking skills in consequential tech, cybersecurity, biotech, health care and life sciences transactions.
She regularly represents Swiss-based global pharmaceutical company Hoffmann-La Roche and its subsidiaries in their U.S. acquisitions. Earlier this year, she helped Roche in its $1.8 billion acquisition of GenMark Dia...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In